First, there is a critical need for the prevention of AKI episodes, underscored by the importance of enhanced patient education regarding their medication regimen, including diuretics, renin-angiotensin system blockers, and mineralocorticoid receptor antagonists. Here, NR3C2 is linked to acute kidney injury.